MedPath

Meperidine

Generic Name
Meperidine
Brand Names
Demerol
Drug Type
Small Molecule
Chemical Formula
C15H21NO2
CAS Number
57-42-1
Unique Ingredient Identifier
9E338QE28F

Overview

A narcotic analgesic that can be used for the relief of most types of moderate to severe pain, including postoperative pain and the pain of labor. Prolonged use may lead to dependence of the morphine type; withdrawal symptoms appear more rapidly than with morphine and are of shorter duration.

Background

A narcotic analgesic that can be used for the relief of most types of moderate to severe pain, including postoperative pain and the pain of labor. Prolonged use may lead to dependence of the morphine type; withdrawal symptoms appear more rapidly than with morphine and are of shorter duration.

Indication

Used to control moderate to severe pain.

Associated Conditions

  • Severe Pain

Clinical Trials

Title
Posted
Study ID
Phase
Status
Sponsor
2025/01/15
Phase 3
Recruiting
2024/12/17
Phase 4
Not yet recruiting
Fondazione Andrea Cesalpino Arezzo ONLUS
2024/08/19
Phase 4
Completed
Ismail Tekin
2024/07/22
Phase 4
Not yet recruiting
2024/03/22
Phase 2
Recruiting
Kasr El Aini Hospital
2023/11/01
Phase 2
Completed
National University of Malaysia
2023/10/13
Phase 2
Not yet recruiting
2023/01/25
Not Applicable
Completed
2022/08/12
Not Applicable
Completed
Medipol University
2022/05/23
Phase 4
UNKNOWN

FDA Drug Approvals

Approved Product
Manufacturer
NDC Code
Route
Strength
Effective Date
Physicians Total Care, Inc.
54868-5808
INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS
50 mg in 1 mL
12/28/2011
Hospira, Inc.
0409-1179
INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS
75 mg in 1 mL
4/2/2024
Hikma Pharmaceuticals USA Inc.
0641-6054
INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS
100 mg in 1 mL
1/30/2024
Physicians Total Care, Inc.
54868-3559
INTRAMUSCULAR
50 mg in 1 mL
5/6/2010
Hospira, Inc.
0409-1362
INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS
25 mg in 1 mL
4/2/2024
Hikma Pharmaceuticals USA Inc.
0054-4595
ORAL
50 mg in 1 1
4/18/2020
Hikma Pharmaceuticals USA Inc.
0641-6052
INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS
25 mg in 1 mL
1/30/2024
Hikma Pharmaceuticals USA Inc.
0641-6053
INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS
50 mg in 1 mL
1/30/2024
Hospira, Inc.
0409-1180
INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS
100 mg in 1 mL
4/2/2024
Validus Pharmaceuticals LLC
30698-337
ORAL
100 mg in 1 1
1/24/2024

EMA Drug Approvals

Approved Product
Authorization Holder
Status
Issued Date
No EMA approvals found for this drug.

HSA Drug Approvals

Approved Product
Manufacturer
Approval Number
Dosage Form
Strength
Approval Date
Pethidine-hameln Solution for Injection 50mg/ml
SIN14662P
INJECTION, SOLUTION
50mg
11/14/2014
DBL PETHIDINE HYDROCHLORIDE INJECTION BP 50mg/ml
SIN00753P
INJECTION
50 mg/ml
5/4/1988

NMPA Drug Approvals

Approved Product
Company
Approval Number
Drug Type
Dosage Form
Approval Date
Pethidine Hydrochloride Injection
国药准字H21022413
化学药品
注射剂
6/15/2020
Pethidine Hydrochloride Injection
国药准字H63020021
化学药品
注射剂
5/13/2020
Pethidine Hydrochloride Injection
国药准字H63020022
化学药品
注射剂
5/13/2020
Pethidine Hydrochloride Injection
国药准字H21023058
化学药品
注射剂
6/15/2020
Pethidine Hydrochloride Injection
国药准字H42022074
化学药品
注射剂
7/16/2020
Pethidine Hydrochloride Tablets
国药准字H63020017
化学药品
片剂
5/13/2020
Pethidine Hydrochloride Tablets
国药准字H63020016
化学药品
片剂
5/13/2020

PPB Drug Approvals

Approved Product
Registration No.
Company
Licence No.
Strength
Registration Date
DEMOTHINE SOLUTION FOR INJECTION 100MG/2ML
N/A
N/A
N/A
1/25/2024
DEMOTHINE SOLUTION FOR INJECTION 50MG/1ML
N/A
N/A
N/A
1/25/2024
© Copyright 2025. All Rights Reserved by MedPath